PGCM
STAB

Prescott Group Capital Management’s Statera Biopharma, Inc. Common Stock STAB Stock Holding History

Prescott Group Capital Management’s Portfolio STAB Stock Details STAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-32,035
Closed -$750K – 223
2013
Q4 		$750K Hold
32,035
– – 0.14% 130
2013
Q3 		$1.01M Sell
32,035
-2,830
-8% -$93.6K 0.21% 104
2013
Q2 		$1.1M Buy
+34,865
New +$1.2M 0.26% 93

Other funds holding STAB

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Prescott Group Capital Management's STAB Position: Q1 2014 in Review

Prescott Group Capital Management sold out of Statera Biopharma, Inc. Common Stock (STAB) in Q1 2014, closing a stake of 32,035 shares — an estimated $750K sold.

Prescott Group Capital Management first reported a position in STAB in Q2 2013 and held it in 3 quarters. The position peaked at $1.1M in Q2 2013. 35 funds tracked by Wall St. Rank hold STAB as of Q1 2014.

  • Prescott Group Capital Management reported no remaining Statera Biopharma, Inc. Common Stock position as of Q1 2014 after selling out during the quarter.
  • Prescott Group Capital Management sold 32,035 Statera Biopharma, Inc. Common Stock shares in Q1 2014, an estimated $750K.
  • Prescott Group Capital Management first reported a position in Statera Biopharma, Inc. Common Stock in Q2 2013 and held it in 3 quarters.
  • Prescott Group Capital Management's Statera Biopharma, Inc. Common Stock position peaked at $1.1M in Q2 2013.
  • 35 funds tracked by Wall St. Rank held Statera Biopharma, Inc. Common Stock as of Q1 2014.

Based on Prescott Group Capital Management's 13F filing for Q1 2014, filed 30 Apr 2014.